Long-Term Follow-Up of the Imatinib GRAAPH-2003 Study in Newly Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A GRAALL Study
Authors:
- Philippe RousselotPRPhilippe Rousselot
- Yves ChalandonYves Chalandon
- Jean-Michel CayuelaJCJean-Michel Cayuela
- Sandrine HayetteSHSandrine Hayette
- Marie-Christiane VekemansMVMarie-Christiane Vekemans
- Martine EscoffreMEMartine Escoffre
- Françoise HuguetFHFrançoise Huguet
- Delphine RéaDRDelphine Réa
- André DelannoyADAndré Delannoy
- Jean-Yves CahnJCJean-Yves Cahn
- Jean-Paul VernantJVJean-Paul Vernant
Open Access
- 1 January 2013
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 19 (1) , 150-155
Abstract
No abstract availableKeywords
Funding Information
- Programme Hospitalier de Recherche Clinique, Ministère de l'Emploi et de la Solidarité (P0200701 and P030425/AOM03081)
This publication has 17 references indexed in Scilit:
- Adult acute lymphoblastic leukemiaCancer, 2010
- First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adultsCurrent Opinion in Oncology, 2009
- Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemiaBone Marrow Transplantation, 2007
- Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocolBlood, 2007
- High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study GroupJournal of Clinical Oncology, 2006
- Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemiaLeukemia, 2005
- The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemiaBlood, 2005
- Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemiaBlood, 2004
- Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylateBlood, 2004
- Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia---results of the prospective multicenter LALA-94 trialBlood, 2002